Cargando…
In Vivo Imaging of GLP-1R with a Targeted Bimodal PET/Fluorescence Imaging Agent
[Image: see text] Accurate visualization and quantification of β-cell mass is critical for the improved understanding, diagnosis, and treatment of both type 1 diabetes (T1D) and insulinoma. Here, we describe the synthesis of a bimodal imaging probe (PET/fluorescence) for imaging GLP-1R expression in...
Autores principales: | Brand, Christian, Abdel-Atti, Dalya, Zhang, Yachao, Carlin, Sean, Clardy, Susan M., Keliher, Edmund J., Weber, Wolfgang A., Lewis, Jason S., Reiner, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215873/ https://www.ncbi.nlm.nih.gov/pubmed/24856928 http://dx.doi.org/10.1021/bc500178d |
Ejemplares similares
-
Development of a clickable bimodal fluorescent/PET probe for in vivo imaging
por: Paulus, Andreas, et al.
Publicado: (2015) -
Chemoenzymatic Strategy for the Synthesis of Site-Specifically
Labeled Immunoconjugates for Multimodal PET and Optical Imaging
por: Zeglis, Brian M., et al.
Publicado: (2014) -
Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model
por: Escorcia, Freddy E., et al.
Publicado: (2018) -
Preloading with Unlabeled CA19.9 Targeted Human Monoclonal
Antibody Leads to Improved PET Imaging with (89)Zr-5B1
por: Houghton, Jacob L., et al.
Publicado: (2017) -
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents
por: Kanagasundaram, Thines, et al.
Publicado: (2021)